Intercept Pharma Banner Image

Intercept Pharma

  • Ticker ICPT
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Intercept Pharma Logo Image
  • 201-500 Employees
  • Based in New York City, New York
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat non-viral, progressive liver diseases, including primary biliary cholangitis (PBC), nonalcoholic steatohepatitis (NASH), primary sclerosing cholangitis (PSC) and biliary atresia.
Intercept Pharma

Most Recent Annual Report

Intercept Pharma MOST RECENT 2019 Annual Report and Form 10K

Report Locked. Intercept Pharma has reached its limit for free report views.

Older/Archived Annual Reports